Cargando…
Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells
Tumor cells harboring stem-like/cancer stem cell (CSC) properties have been identified and isolated from numerous hematological and solid malignancies. These stem-like tumor cells can persist following conventional cytoreductive therapies, such as chemotherapy and radiotherapy, thereby repopulating...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356940/ https://www.ncbi.nlm.nih.gov/pubmed/30646520 http://dx.doi.org/10.3390/cancers11010085 |